Search
9 articles for “HPV vaccine”
-
HPV Vaccination: Broader Implementation and Development of Next-Generation Vaccines Reduce the Incidence of Cervical Cancer
Abstract: Cervical cancer has been an important health issue of global concern which has almost universally been fuelled by the persistent infection of high-risk Human Papillomavirus (HPV). The most effective way of primary prevention is prophylactic HPV vaccination. The extensive real-world evidence obtained through national immunization programs throughout the world has given unambiguous evidence of the effect of the vaccine as a decline in the incidence of high-grade cervical pre-cancers and …
Published in Research and Reviews : A Journal of Immunology · Vol. 16, Issue 1, 2026 · pp. 11–20 Read article
-
Impact of a Structured Educational Program on Awareness of the Human Papilloma Virus Vaccine for Cervical Cancer Prevention Among Women in a Chosen Rural Region of Rajkot
Abstract: The World Health Organization (WHO) advocates for the inclusion of the human papilloma virus (HPV) vaccine in standard immunization schedules worldwide, in addition to other preventive strategies. The launch of the prophylactic HPV vaccine has markedly improved primary prevention measures against cervical cancer and other diseases caused by HPV. Following their approval in 2006, both the quadrivalent and bivalent HPV vaccines have received authorization in over 100 countries. As of …
Published in International Journal of Oncological Nursing and Practices · Vol. 2, Issue 1, 2024 · pp. 18–22 Read article
-
HPV and Cardiovascular Risk: Unpacking a Novel Link Between Viral Infection and Heart Disease
Abstract: Human papillomavirus (HPV) is best known for its oncogenic potential, yet a growing body of evidence suggests that persistent HPV infection may also contribute to cardiovascular disease (CVD). In 2025, pooled analyses and conference reports galvanized attention by estimating that HPV‐positive individuals have ~40% higher risk of CVD and approximately double the risk of coronary artery disease (CAD) compared with HPV‐negative peers, even after adjustment for traditional risk factors. These …
Published in International Journal of Virus Studies · Vol. 2, Issue 2, 2025 · pp. 1–5 Read article
-
Challenges to Women's Adoption of the Human Papillomavirus Vaccine in India: An Updated Review
Abstract: The widespread availability of human papillomavirus (HPV) vaccines in some countries throughout the last ten years has demonstrated encouraging outcomes in reducing HPV infection and associated conditions including warts and precancerous lesions. We highlight vaccination coverage and efficacy in this study, which includes the most recent data on available HPV vaccinations. Furthermore, the topic of pan-gender immunisation and ongoing clinical trials is covered. Increasing vaccination coverage is now something that …
Published in International Journal of Vaccines · Vol. 2, Issue 2, 2025 · pp. 21–30 Read article
-
Effectiveness of structured teaching programme on knowledge regarding Prophylactic vaccination against cervical cancer among adolescent girls
Abstract: Background: Adolescent health encompasses the variety of methods used to prevent, identify, or treat the health and wellness of young people. Adolescent health also includes the sexual and reproductive health of children and young adults. Women of all ages are susceptible to HPV infection. The human papillomavirus is the cause of cervical cancer . The HPV vaccine is an important main preventive measure against cervical cancer . Thus, it is …
Published in International Journal of Vaccines · Vol. 2, Issue 2, 2025 Read article
-
Knowledge, Awareness, and Perceptions of Cervical Cancer and Screening Among Women in Rural South India
Abstract: Background: Cervical cancer is still a major public health problem in South India, with rising figures of morbidity and mortality, in spite of progress in prevention, early detection, and treatment. Cervical cancer is the second leading cause of death due to cancer among Indian women, with around 123000 new cases and 67000 deaths every year. The delay in diagnosing CVD and low participation in screening programs is due to poor …
Published in International Journal of Oncological Nursing and Practices · Vol. 3, Issue 2, 2025 · pp. 1–8 Read article
-
Awareness Regarding Cervical Cancer among Women Attending a Selected Hospital in Lucknow, Uttar Pradesh: A Cross-Sectional Study.
Abstract: Cervical cancer continues to be a significant health concern, particularly in low- and middle-income countries like India, where it remains a leading cause of cancer-related deaths among women. Despite the availability of preventive measures such as the Human Papillomavirus (HPV) vaccine and screening techniques like Pap smears, a considerable gap in awareness persists. Limited knowledge of cervical cancer, its risk factors, symptoms, and preventive strategies hampers the effectiveness of early …
Published in International Journal of Women's Health Nursing And Practices · Vol. 3, Issue 2, 2025 · pp. 19–24 Read article
-
Cervical Cancer: Understanding Its Causes, Risk Factors, and Preventive Measures
Abstract: Cervical cancer is a form of cancer that begins in the cervix, the lower portion of the uterus, due to abnormal cell growth that can spread or invade other areas of the body. In its early stages, cervical cancer usually shows no obvious symptoms, which is why regular screenings are essential for detecting it early. As the cancer advances, symptoms such as pelvic pain, unusual vaginal bleeding, and pain during …
Published in International Journal of Oncological Nursing and Practices · Vol. 3, Issue 1, 2025 · pp. 26–30 Read article
-
CRISPR, Recombinant DNA, and LAMP-Based Platforms for Monkeypox: Emerging Tools for Diagnosis and Therapeutic Development
Abstract: Monkeypox, a zoonotic viral infection caused by the Monkeypox virus of the Orthopoxvirus genus, has recurred as a worldwide public health concern after recent outbreaks outside of its classical endemic areas in Central and West Africa. The resurgence has demanded a thorough reassessment of its epidemiology, mode of transmission, and clinical presentation. In light of these challenges, recombinant DNA technology (rDNA) has emerged as a candidate for developing vaccines, diagnostics, …
Published in International Journal of Virus Studies · Vol. 3, Issue 1, 2026 · pp. 7–28 Read article